Skip to main content
Journal of Applied Physiology logoLink to Journal of Applied Physiology
. 2022 May 5;133(4):913–916. doi: 10.1152/japplphysiol.00058.2022

Revisiting the effects of the reciprocal function between alveolar ventilation and CO2 partial pressure (PACO2) on PACO2 homeostasis at rest and in exercise

Philippe Haouzi 1,
PMCID: PMC9829475  PMID: 35511724

This paper discusses some of the clinically relevant effects of the “reciprocal (1/x) nature” of the function linking alveolar ventilation (V̇A, the volume of gas mobilized in the lungs, per unit of time, contributing to the pulmonary gas exchanges) to the mean partial pressure of CO2 in the alveolar gas (PACO2). This reciprocal function exerts fundamental constraints on the control of respiration, which are essential for alveolar gases homeostasis and stability, at rest and in exercise. This function also imposes major ventilatory challenges during heavy exercise, as hypocapnia develops.

THE PLANT GAIN OF THE RESPIRATORY SYSTEM IS A RECIPROCAL SQUARED FUNCTION OF ALVEOLAR VENTILATION: THE MAGNITUDE OF CHANGES IN PACO2 (FOR A GIVEN CHANGE IN ALVEOLAR VENTILATION) INCREASES AS V̇A DECREASES

If one neglects the insignificant amount of CO2 in the air, PACO2 and thus PCO2 in the arterial blood (PaCO2) are dictated, in steady-state conditions, by the ratio between the volume of CO2 exchanged in the lungs per unit of time [carbon dioxide output (V̇co2)] and V̇A (1):

PACO2= K·V˙CO2·V˙A1. (1)

If V̇co2 is expressed in milliliter per minute in STPD conditions and V̇A in L/min in BTPS conditions, then K which has the dimension of a pressure is equal to 0.863 (1). This relationship is displayed in Fig. 1. In a resting subject (V̇co2 ∼ 230 mL/min), V̇A of ∼5 L/min is required to maintain isocapnia (PACO2 ∼ 40 mmHg). This figure shows that the magnitude of the change in PACO2 for 1 L/min change in alveolar ventilation, referred to as the respiratory plant gain for CO2 (RPGCO2), varies according to the level of alveolar ventilation in a nonlinear manner. Mathematically, the slope of the tangent of the V̇A/PACO2 relationship, i.e., RPGCO2, is the first derivative of PACO2 over V̇A (dPACO2/dV̇A) as illustrated in Fig. 1, A and B:

dPACO2/dV˙A=((K·V˙CO2·V˙A1)·V˙A1) =(K·V˙CO2·V˙A2). (2)

Figure 1.

Figure 1.

A: relationship between V̇A and PACO2 in a resting adult subject. The 1/x nature of the relationship between V̇A and PACO2 (PACO2 = K·V̇co2·V̇A−1) accounts for the fact that when V̇A decreases, any given change in V̇A produces larger and larger increase in PACO2: the respiratory plant gain for CO2 (RPGCO2), i.e., the slope of tangent of V̇A-PACO2 relationship (shown in blue dotted line) increases as V̇A decreases. B: values of PACO2 as well as the slopes of the tangent of the V̇A-PACO2 relationship (RPGCO2) at three different levels of V̇A (5 L/min, 2.5 L/min, and 1.25 L/min) when a subject hypoventilates. C: effect of increasing inspired PCO2 (PICO2) by 15 or 40 mmHg on the V̇A-PACO2 function at rest. A higher PICO2 shifts up the V̇A-PACO2 relationship by an amount corresponding to PICO2 but does not alter the slope of the tangent of V̇A-PACO2 function (at any given level of V̇A, V̇co2/V̇A remains the same as during air breathing). Since an increase in PICO2 rises mean PaCO2, any ventilatory stimulation resulting from this increase in PaCO2 allows the respiratory system to operate in the “hyperventilation range,” where RPGCO2 is lower. The dotted lines represent the range of the controller gain values from 1 L/min/mmHg (low sensitivity) to 3 L/min/mmHg (high sensitivity). A B, and C are the RPGCO2 values for V̇A ∼ 5, 8, and 35 L/min, respectively; note that RPGCO2 is independent of the mechanism producing the increase in alveolar ventilation and thus of mean PA(a)CO2. D: example of the effects of an increase in metabolism, produced by a muscular exercise, on the relationship between V̇A and PACO2. The relationship shifts up and to the right during a muscular exercise in keeping with the level of V̇co2. However, 1) PACO2 is maintained constant (or even decreased at high intensity exercise) due to the proportional increase in V̇A and V̇co2, a fundamental tenet of exercise hyperpnea, 2) due to higher metabolism, the slope of the tangent (blue dotted lines) of the V̇A-PACO2 relationship (RPGCO2), at a CO2 set point of 40 mmHg, decreases during exercise. E: tangent values of the V̇A-PACO2 relationship (RPGCO2) at the two different levels of metabolism shown in C, illustrating how much change in V̇A would be needed to keep PACO2 within a normal range at rest and in exercise: fluctuations of V̇A by ∼ 10 L/min can lead to changes in PACO2 between 37 and 44 mmHg during exercise (V̇co2 = 2.3 L/min), whereas similar changes in PACO2 would be produced by fluctuations of less than 1 L/min at rest (V̇co2 = 0.23 L/min). F: values of the slope of the tangent of V̇A-PACO2 relationship (RPGCO2) as a function of V̇co2 at two different levels of PACO2 (40 and 30 mmHg). Note that the Y axis, −dPACO2/dV̇A, is expressed with positive values for clarity. RPGCO2 decreases as a function of V̇co2. PACO2, partial pressure of CO2 in the alveolar gas; PaCO2, PCO2 in the arterial blood; PICO2, inspired PCO2; RPGCO2, respiratory plant gain for CO2; V̇A, alveolar ventilation; V̇co2, carbon dioxide output.

RPGCO2 is therefore a function of V̇A−2. In other words, RPGCO2 is low when V̇A is high but dramatically increases when V̇A decreases, as illustrated in Fig. 1, A and B. For instance, a decrease in V̇A by half (from 5 to 2.5 L/min) doubles PACO2 (from 40 to 80 mmHg), leading to an average change in PACO2 of 16 mmHg for every liter per minute change in alveolar ventilation. An additional reduction in V̇A by half (from 2.5 to 1.25 L/min), will again double PACO2, i.e., from 80 to 160 mmHg; as a result, PACO2 now has changed by 64 mmHg for every liter per minute change in alveolar ventilation. As shown in Fig. 1B, the absolute value of the slope of the tangent of V̇A-PACO2 function (RPGCO2) at V̇A of, for instance, 5, 2.5, and 1.25 L/min (PACO2 of 40, 80, and 160 mmHg) averages 8, 32, and 128 mmHg/L/min, respectively, increasing dramatically as V̇A decreases.

This simple observation helps us to understand why a patient who is already hypoventilating (already hypercapnic) “requires” smaller decrements in alveolar ventilation than if normocapnic, to increase PACO2. Conversely, a smaller increment in alveolar ventilation will be needed to bring PACO2 from 100 to 60 mmHg than from 50 to 40 mmHg. In the “hyperventilation” range, RPGCO2 continues to decrease as V̇A increases, dropping for instance from 8 to 2 mmHg/L/min as V̇A rises from 5 to 10 L/min.

Of note, increasing inspired PCO2 (PICO2) has an intriguing effect on RPGCO2. As illustrated in Fig. 1C, a higher PICO2 does not alter the slope of the tangent of the V̇A-PACO2 function, as at any given level of V̇A, the ratio V̇co2/V̇A remains unchanged regardless of PICO2. During inhalation of CO2, the V̇A-PACO2 relationship is shifted up by a value corresponding to PICO2:

PACO2 = [K·V˙CO2·V˙A1]+PICO2. (3)

However, any additional stimulation of V̇A resulting from an increase in mean PACO2 will displace the new PCO2 set point on the V̇A-PACO2 relationship toward the “high ventilation range” (with respect to V̇co2) leading to a reduced RPGCO2. Therefore, any increased ventilation produced by an increase in mean PACO2, resulting from CO2 inhalation, decreases RPGCO2. In other words, for a given V̇co2, RPGCO2 is dictated by the absolute level of ventilation reached in response to an increased mean PACO2. For instance (Fig. 1C), assuming that inhaling a given % in CO2 results in a new PaCO2 set point of 50 mmHg, which would have increased V̇A to ∼ 20 L/min, RPGCO2 would drop by 20 times (0.4 mmHg/L/min versus 8 mmHg/L/min during air breathing with a PaCO2 set point ∼ 40 mmHg and V̇A ∼ 5 L/min). This effect should not be confused with conditions wherein PACO2 increases due to hypoventilation, which is always associated to an increase in RPGCO2 (Fig. 1, A and B). The consequence of this effect on periodic breathing (PB) is discussed in the following paragraph.

THE PLANT GAIN OF THE RESPIRATORY SYSTEM IS A RECIPROCAL FUNCTION OF EXERCISE INTENSITY: THE CHALLENGE OF MAINTAINING ISOCAPNIA (OR PRODUCING HYPOCAPNIA) WHEN V̇co2 INCREASES

As illustrated in Fig. 1, D and E, increasing V̇co2 during a muscular exercise shifts the V̇A-PACO2 relationship up and to the right, in turn dramatically decreasing RPGCO2 at any given CO2 set point. Indeed, the fundamental characteristic of the ventilatory response to a muscular exercise, at least in humans, is to maintain PACO2 constant (i.e., V̇A increases in proportion to V̇co2, Fig. 1D; 24), whereas hypocapnia develops during heavy exercise (5). When V̇co2 increases in isocapnic condition, RPGCO2 displays an inverse function of the gas exchange rate (Fig. 1, E and F). Any given change in V̇A, therefore, has a much lower impact on PACO2 during exercise than at rest. For example, at a PACO2 ∼ 40 mmHg, the first derivative of PACO2 over V̇A will reach ∼8 mmHg/L/min at rest versus 0.8 mmHg/L/min for a V̇co2 of 2.5 L/min. Another way to look at this property is illustrated in Fig. 1E, which shows that for keeping PACO2 between 37 and 44 mmHg (within the normal range) V̇A must change by ∼ 1 L/min at rest versus ∼ 9 L/min during our chosen level of exercise. This also implies that very large changes in V̇A must be generated to produce hypocapnia during heavy exercise (5; Fig. 1F): it takes more than 30 L/min of increment in alveolar ventilation (and much more in terms of minute ventilation) to only decrease PACO2 from 40 to 30 mmHg during heavy exercise compared with ∼ 2 L/min at rest; as a result, PACO2 is more “immune” to fluctuations in ventilation during exercise than at rest. This property is illustrated in Fig. 1F, displaying the changes in RPGCO2 as a function of exercise intensity; for a V̇co2 = 3.4 L/min, RPGCO2 would be ∼ 30 times less than at rest.

EFFECTS OF THE RECIPROCAL FUNCTION BETWEEN ALVEOLAR VENTILATION AND CO2 PARTIAL PRESSURE ON PERIODIC BREATHING AT REST AND IN EXERCISE

One of the widely accepted mechanisms put forward to account for the generation of periodic breathing (PB) assumes that PB can be generated by self-sustained cyclic oscillations in arterial PCO2 and in minute ventilation (6). As ventilation diminishes, PA(a)CO2 increases; this transient hypercapnia produces in turn a stimulation of breathing leading to a reversal of the changes in PA(a)CO2 depressing breathing again, and a new cycle of oscillations can be produced (6). In this model, the generation and maintenance of PB therefore depends on three fundamental components: 1) the sensitivity of the structures involved in the chemical control of breathing usually referred as “the controller gain,” which can be described in terms of changes ventilation produced by given changes in PaCO2 (7); 2) the gain of the controlled system (plant gain), i.e., how much PaCO2 changes for a given change in ventilation (RPGCO2); and 3) the frequency response (delays and time constant) of the chemical regulation of breathing as well as of the systems eluting then storing CO2 in the lungs, blood, and tissues.

Although associated with a reduced RPGCO2, hypocapnia is present in various types of PB including altitude-induced hypoxemia or in heart failure (8). Increasing PICO2 blunts or even suppresses the production of PB (810). The mechanisms through which increasing PICO2 could affect PB can be quite counterintuitive. Preventing/limiting the decrease in PACO2 when V̇A is at its peak could certainly reduce the magnitude of PACO2 oscillations. In addition, as discussed earlier, rising mean PACO2 has a stimulatory effect on ventilation that results in an additional reduction in RPGCO2 (Fig. 1B), which, in and of itself, can blunt PB production (11). This “protective” effect of an increased ventilation (Fig. 1, A and C) has already been put forward as a mechanism of reduction in the propensity for central and cyclical sleep apnea following acetazolamide-induced hyperventilation for instance (11). Correcting hypocapnia by increasing PICO2 could therefore produce an additional decrease in RPGCO2 via the resulting additional elevation in ventilation, in turn impeding PB production (810).

PB also occurs during exercise in patients with chronic heart failure (CHF; 12, 13), producing large oscillations in ventilation with periods of ∼ 45–60 s and 10 L/min amplitude (14, 15). PB in cardiac patients is typically associated with a poor prognosis (14, 16). The dramatic reduction of RPGCO2 as exercise intensity increases (Fig. 1F) makes the controller system more critically dependent on its response kinetics than at rest for generating self-sustained PB, since changes in PACO2 for a given change in ventilation are considerably decreased when compared with rest. Indeed, in unsteady conditions, the amplitudes of oscillations in ventilation are not only dictated by the amplitudes of the changes in PA(a)CO2 at the level of chemoreceptors, but also by the frequency response of V̇e response to PA(a)CO2 oscillations. As a first approximation, the time constant (τ) of the V̇e response to a change in PACO2 can be estimated in healthy adult subjects to be around 70 s; this figure was based on the studies of the V̇e response to PaCO2 in response to sinusoidal, impulse, or step forcing [for review, see Ref (7)]. Considering that the ventilatory response to a given change in PACO2 can be described as a first order system (17), the amplitude (A) of ventilatory oscillations, resulting from oscillations in PACO2 can be written as

A=ASS/[1+2π·f·τ)2]0.5 (4)

where ASS is the amplitude response in steady-state condition (17), f is the frequency of PaCO2 oscillations, and τ is the overall time constant of the V̇e response to PACO2 changes. Steady-state chemosensitive gains (ASS) averaging 2.4 L/min/mmHg have been reported in patients with heart failure presenting PB versus 0.85 L/min/mmHg in patients with CHF with no PB (18). Even with such a high gain, the amplitude of V̇e oscillations would at best reach 0.40 L/min/mmHg in response to 45–60-s period blood gas oscillations (in keeping with Eq. 4). The combination of a very low plant gain during exercise and a low amplitude response of the chemical control system (in keeping with its frequency response and the periods of oscillations) certainly represents a major challenge to sustain PB during a muscle exercise, at least via the sole cyclic self-maintenance of oscillations in arterial PCO2 and ventilation. The observation that primary large swings in V̇co2 (and V̇o2) out of phase with the changes in ventilation, are present during PB in exercise (19), changing the numerator of the alveolar gas equation (Eq. 1), could allow for a simple solution to this conundrum. Indeed, even if the mechanisms leading to the production of large swings in V̇co2 and V̇o2 during PB are not fully understood, out of phase oscillations in V̇o2 and ventilation can certainly result in swings in PACO2 and thus could still fit with the general model of Cherniack and Longobardo (6). Alternatively, one can propose that the presence of large oscillations in V̇co2 and V̇o2 during PB (20), or one of their circulatory surrogates (19), could “force” ventilation to oscillate, regardless of any CO2 error signal, akin to the still debated mechanisms of exercise hyperpnea (24). This could represent a mechanism of production of PB, revealed by exercise, whose role, if any, in resting conditions would need to be investigated.

In conclusion, the nature of the function linking V̇A and PACO2 affects the stability of the respiratory system: the capacity of ventilation to elute CO2, for a given change in alveolar ventilation, is reduced in exercise, as well as during any stimulation of ventilation out of proportion of the pulmonary gas exchange rate (including stimulations produced by increased inspired CO2), whereas it is enhanced by several folds during hypoventilation. This effect could be seen as a rudimentary mechanism contributing to PACO2 homeostasis during exercise-induced hyperpnea by rendering changes in PACO2 more immune from fluctuations in ventilation than at rest, at the expense of a heavy ventilatory requirement, when intensity increases and hypocapnia develops.

DISCLOSURES

No conflicts of interest, financial or otherwise, are declared by the author.

AUTHOR CONTRIBUTIONS

P.H. prepared figure; drafted manuscript; edited and revised manuscript; approved final version of manuscript.

REFERENCES

  • 1. Otis AB. Quantitative relationships in steady-state gas exchange. In: Handbook of Physiology, Section 3: Respiration, edited by Fenn WO, and Rahn H.. Washington, DC: American Physiological Society, 1964, Vol. 1, p. 681–698. [Google Scholar]
  • 2. Forster HV, Haouzi P, Dempsey JA. Control of breathing during exercise. Compr Physiol 2: 743–777, 2012. doi: 10.1002/cphy.c100045. [DOI] [PubMed] [Google Scholar]
  • 3. Haouzi P. Tracking pulmonary gas exchange by breathing control during exercise: role of muscle blood flow. J Physiol 592: 453–461, 2014. [Erratum in J Physiol 592: 3161, 2014]. doi: 10.1113/jphysiol.2013.261396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Whipp B, Ward S. Coupling of ventilation to pulmonary gas exchange during exercise. In: Exercise Pulmonary Physiology and Pathophysiology, Lung Biology in Health and Disease, edited by Whipp B, and Wasserman K.. New York: Marcel Dekker, 1991, p. 271–307. [Google Scholar]
  • 5. Dempsey JA, La Gerche A, Hull JH. Is the healthy respiratory system built just right, overbuilt, or underbuilt to meet the demands imposed by exercise? J Appl Physiol (1985) 129: 1235–1256, 2020. doi: 10.1152/japplphysiol.00444.2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Cherniack NS, Longobardo GS. Mathematical models of periodic breathing and their usefulness in understanding cardiovascular and respiratory disorders. Exp Physiol 91: 295–305, 2006. doi: 10.1113/expphysiol.2005.032268. [DOI] [PubMed] [Google Scholar]
  • 7. Cunningham DJC, Robbins PA, Wolff CB. Integration of respiratory responses to changes in alveolar partial pressures of CO2 and O2 and in arterial pH. In: Handbook of Physiology, Section 3, The Respiratory System, edited by Fishman AP, Cherniack NS, and Widdicombe JG.. Bethesda: American Physiological Society, 1986, Vol. 2, p. 475–528. [Google Scholar]
  • 8. Lorenzi-Filho G, Rankin F, Bies I, Douglas Bradley T. Effects of inhaled carbon dioxide and oxygen on cheyne-stokes respiration in patients with heart failure. Am J Respir Crit Care Med 159: 1490–1498, 1999. doi: 10.1164/ajrccm.159.5.9810040. [DOI] [PubMed] [Google Scholar]
  • 9. Berssenbrugge A, Dempsey J, Iber C, Skatrud JS, Wilson P. Mechanisms of hypoxia-induced periodic breathing during sleep in humans. J Physiol 343: 507–524, 1983. doi: 10.1113/jphysiol.1983.sp014906. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Xie A, Teodorescu M, Pegelow DF, Teodorescu MC, Gong Y, Fedie JE, Dempsey JA. Effects of stabilizing or increasing respiratory motor outputs on obstructive sleep apnea. J Appl Physiol (1985) 115: 22–33, 2013. doi: 10.1152/japplphysiol.00064.2013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Dempsey JA. Central sleep apnea: misunderstood and mistreated!. F1000Res 8: 981, 2019. doi: 10.12688/f1000research.18358.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Ribeiro JP, Knutzen A, Rocco MB, Hartley LH, Colucci WS. Periodic breathing during exercise in severe heart failure. Reversal with milrinone or cardiac transplantation. Chest 92: 555–556, 1987. doi: 10.1378/chest.92.3.555. [DOI] [PubMed] [Google Scholar]
  • 13. Agostoni P, Corrà U, Emdin M. Periodic breathing during incremental exercise. Ann Am Thorac Soc 14: S116–S122, 2017. doi: 10.1513/AnnalsATS.201701-003FR. [DOI] [PubMed] [Google Scholar]
  • 14. Corrà U, Pistono M, Mezzani A, Braghiroli A, Giordano A, Lanfranchi P, Bosimini E, Gnemmi M, Giannuzzi P. Sleep and exertional periodic breathing in chronic heart failure: prognostic importance and interdependence. Circulation 113: 44–50, 2006. doi: 10.1161/CIRCULATIONAHA.105.543173. [DOI] [PubMed] [Google Scholar]
  • 15. Agostoni P, Apostolo A, Albert RK. Mechanisms of periodic breathing during exercise in patients with chronic heart failure. Chest 133: 197–203, 2008. doi: 10.1378/chest.07-1439. [DOI] [PubMed] [Google Scholar]
  • 16. Leite JJ, Mansur AJ, de Freitas HF, Chizola PR, Bocchi EA, Terra-Filho M, Neder JA, Lorenzi-Filho G. Periodic breathing during incremental exercise predicts mortality in patients with chronic heart failure evaluated for cardiac transplantation. J Am Coll Cardiol 41: 2175–2181, 2003. doi: 10.1016/s0735-1097(03)00460-1. [DOI] [PubMed] [Google Scholar]
  • 17. Bouyssy A, Davier M, Gatty B. La physique et ses méthodes. Physique pour les sciences de la vie. Paris: Belin, 1978. [Google Scholar]
  • 18. Francis DP, Willson K, Davies LC, Coats AJ, Piepoli M. Quantitative general theory for periodic breathing in chronic heart failure and its clinical implications. Circulation 102: 2214–2221, 2000. doi: 10.1161/01.CIR.102.18.2214. [DOI] [PubMed] [Google Scholar]
  • 19. Ben-Dov I, Sietsema KE, Casaburi R, Wasserman K. Evidence that circulatory oscillations accompany ventilatory oscillations during exercise in patients with heart failure. Am Rev Respir Dis 145: 776–781, 1992. doi: 10.1164/ajrccm/145.4_Pt_1.776. [DOI] [PubMed] [Google Scholar]
  • 20. Francis DP, Davies LC, Piepoli M, Rauchhaus M, Ponikowski P, Coats AJ. Origin of oscillatory kinetics of respiratory gas exchange in chronic heart failure. Circulation 100: 1065–1070, 1999. doi: 10.1161/01.CIR.100.10.1065. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Applied Physiology are provided here courtesy of American Physiological Society

RESOURCES